Earnings
Lower Prices Cost EOG Resources $0.49 Per Share As Production Gains Fall Short
Adjusted profit fell from the second quarter, while EOG continued buying back shares and paying dividends.
Product + growth @TheBullished. I build the software that writes the stories you read, and get them in front of as many people as possible.
Earnings
Adjusted profit fell from the second quarter, while EOG continued buying back shares and paying dividends.
SEC Filings
Record quarterly sales and faster software growth came alongside a lower cash-flow forecast and a planned $1.2 billion Skydio investment.
Earnings
The app company raises its 2026 outlook as paying users grow, but a U.K. settlement helps push the third quarter into a loss.
Earnings
MIMRYLO approval payments drove the earnings reversal as Protagonist funds its own drug candidates and plans share repurchases.
Earnings
F&G contributed less adjusted profit as ownership declined and insurance costs rose, while market-value gains lifted accounting earnings.
SEC Filings
The client relationship now includes about $50 million in deposits, while other examples add financing and investment-banking opportunities.
SEC Filings
The drug developer bought manufacturing assets for $8.75 million and expects bladder-cancer trial enrollment to finish by year-end.
Earnings
Third-quarter net earnings reached approximately C$3.0 billion, while Horizon maintenance and lower prices held results below the second quarter.
SEC Filings
Cogent expects its $791.1 million cash and securities balance to fund operations and capital spending into late 2028.
SEC Filings
The hospital operator may use the money to retire 2027 bonds and repay short-term borrowings.
SEC Filings
The quarterly shareholder loss widened to $11.6 million, while management expects cash to cover operations beyond the trial readout.
Earnings
The aircraft-engine services company also intends to repurchase $350 million of shares, while component repair earnings fell.